Article
FDA Approves First New Mesothelioma Treatment in 16 Years
Rating:
0.0
Views:
30
Likes:
1
Library:
1
The FDA announced it has approved Bristol-Myers Squibb's Opdivo (nivolumab) in combination with Yervoy (ipilimumab) to treat malignant pleural mesothelioma.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value